David M. Knott’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$2.09M Buy
10,416
+864
+9% +$173K 0.76% 34
2021
Q2
$2.44M Buy
9,552
+334
+4% +$85.4K 0.87% 32
2021
Q1
$2.45M Sell
9,218
-617
-6% -$164K 1.05% 28
2020
Q4
$3.63M Buy
9,835
+657
+7% +$242K 1.64% 15
2020
Q3
$2.24M Buy
9,178
+386
+4% +$94.3K 1.31% 18
2020
Q2
$2.53M Hold
8,792
1.38% 17
2020
Q1
$1.79M Buy
8,792
+977
+13% +$199K 1.13% 21
2019
Q4
$3.49M Hold
7,815
1.42% 17
2019
Q3
$2.4M Buy
7,815
+583
+8% +$179K 1.01% 20
2019
Q2
$2.3M Buy
7,232
+2,854
+65% +$908K 0.97% 21
2019
Q1
$1.84M Hold
4,378
0.73% 30
2018
Q4
$1.33M Buy
4,378
+1,022
+30% +$311K 0.63% 32
2018
Q3
$1.21M Buy
3,356
+297
+10% +$107K 0.39% 38
2018
Q2
$1.12M Buy
3,059
+997
+48% +$365K 0.42% 38
2018
Q1
$609K Buy
2,062
+1,329
+181% +$393K 0.25% 55
2017
Q4
$307K Buy
733
+373
+104% +$156K 0.12% 72
2017
Q3
$119K Buy
+360
New +$119K 0.05% 85